Depression was shown to decrease endogenous estradiol levels, resulting in the upregulation of NOTCH3, which facilitated GC progression by decreasing mitochondrial injury and shaping an immunosuppressive microenvironment. Here, NOTCH3 is linked to depressive symptom measurement.